Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rayid Abdulqawi

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|February 27, 2013
Gabapentin for refractory chronic coughRayid Abdulqawi, Ashley Woodcock, Jaclyn A Smith
Current Gastroenterology Reports|April 6, 2011
GERD-related cough: pathophysiology and diagnostic approachJaclyn A Smith, Rayid Abdulqawi, Lesley A Houghton
BMJ Case Reports|November 10, 2022
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a rare cause of airflow limitationRayid Abdulqawi, Janat Alsaif, Huda Ismail, et al.
Pediatric Transplantation|July 4, 2026
Single-Center Experience in Pediatric Lung Transplantation: Clinical Characteristics, Survival, and Post-Transplant MorbidityMohammed Albalawi, Rayid Abdulqawi, Abdullah Alkhani, et al.
BMJ Case Reports|July 25, 2022
Precalcific phase of pulmonary alveolar microlithiasisAhmed Aljishi, Suha H Al-Badr, Najla Aldaoud, et al.
Future Hospital Journal|May 18, 2019
An analysis of ambulatory emergency care (AEC) performance following participation by specialty consultants with general internal medical skillsPradeep Mallisetty, Rayid Abdulqawi, Grainne Clarke, et al.
ERJ Open Research|September 22, 2021
An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic coughRayid Abdulqawi, Imran Satia, Kimberley J Holt, et al.
Lancet (London, England)|July 22, 2015
P2X3 receptor antagonist in chronic cough--Authors' replyJaclyn A Smith, Rayid Abdulqawi, Rachel Dockry, et al.
Saudi Journal of Medicine & Medical Sciences|May 30, 2023
Diagnostic Utility of Bronchoalveolar Lavage in Immunocompromised Patients with Lung InfiltratesAhmed Aljishi, Deemah Alalbdulhadi, Ghadeer Alabbadi, et al.
Lancet (London, England)|December 4, 2014
P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 studyRayid Abdulqawi, Rachel Dockry, Kimberley Holt, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|February 27, 2013
Gabapentin for refractory chronic coughRayid Abdulqawi, Ashley Woodcock, Jaclyn A Smith
Current Gastroenterology Reports|April 6, 2011
GERD-related cough: pathophysiology and diagnostic approachJaclyn A Smith, Rayid Abdulqawi, Lesley A Houghton
BMJ Case Reports|November 10, 2022
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a rare cause of airflow limitationRayid Abdulqawi, Janat Alsaif, Huda Ismail, et al.
Pediatric Transplantation|July 4, 2026
Single-Center Experience in Pediatric Lung Transplantation: Clinical Characteristics, Survival, and Post-Transplant MorbidityMohammed Albalawi, Rayid Abdulqawi, Abdullah Alkhani, et al.
BMJ Case Reports|July 25, 2022
Precalcific phase of pulmonary alveolar microlithiasisAhmed Aljishi, Suha H Al-Badr, Najla Aldaoud, et al.
Future Hospital Journal|May 18, 2019
An analysis of ambulatory emergency care (AEC) performance following participation by specialty consultants with general internal medical skillsPradeep Mallisetty, Rayid Abdulqawi, Grainne Clarke, et al.
ERJ Open Research|September 22, 2021
An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic coughRayid Abdulqawi, Imran Satia, Kimberley J Holt, et al.
Lancet (London, England)|July 22, 2015
P2X3 receptor antagonist in chronic cough--Authors' replyJaclyn A Smith, Rayid Abdulqawi, Rachel Dockry, et al.
Saudi Journal of Medicine & Medical Sciences|May 30, 2023
Diagnostic Utility of Bronchoalveolar Lavage in Immunocompromised Patients with Lung InfiltratesAhmed Aljishi, Deemah Alalbdulhadi, Ghadeer Alabbadi, et al.
Lancet (London, England)|December 4, 2014
P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 studyRayid Abdulqawi, Rachel Dockry, Kimberley Holt, et al.
Pageof 4